Ending the HIV Epidemic:
HIV Testing & Prevention TeleECHO Series
1
HIV Epidemiology & Screening Guidelines
SCAETC Regional Collaborative Training
2
Disclosures
 Original slide developer: Michelle Iandiorio, MD
 Clinical Director, SCAETC; Professor, UNMHSC Dept of Internal
Med, Division of Infectious Diseases
 Slide developer has no financial conflicts of interest to disclose
 Slide presenter has spoken for Merck in the past
3
This program is supported by the Health Resources and Services Administration (HRSA) of the U.S. Department of Health and Human
Services (HHS) as part of an award totaling $3,132,205, with 0% financed with non-governmental sources.
The views expressed do not necessarily reflect the official policies of the Department of Health and Human Services, nor does mention
of trade names, commercial practices, or organizations imply endorsement by the U.S. Government. Any trade/brand names for
products mentioned during this presentation are for training and identification purposes only.
This project is supported by funds from the Bureau of Primary Care.
Learning Objectives
1. Recognize the need for HIV screening and prevention.
2. Recognize disparities in accessing HIV prevention.
3. Identify HIV screening guidelines and explain why HIV
screening is routine best practice.
4. Explain status neutral linkage to care.
4
There have been improvements in reduction of new
HIV diagnoses…
 Annual number of new diagnoses decreased 8%
from 2015 to 2019 in U.S. (36,000)
 Majority of new diagnoses in men with male sex
partners
 From 2010 to 2019, HIV diagnoses decreased
among youth overall
 2019 HIV infections decreased among 13-
24yo by 46%
https://www.cdc.gov/hiv/statistics/overview/ataglance.html
… But Disparities Still Exist
 New HIV diagnoses in Native American population
increased 22% between 2015 to 2019 (31% in
Native American men with male sex partners)
 From 2010 to 2016, HIV diagnoses increased 6%
among Latinx
 The most affected subpopulation is African
American/Black gay and bisexual men
https://www.cdc.gov/hiv/statistics/overview/ataglance.html
MSM=men who have sex with men
https://www.cdc.gov/hiv/statistics/overview/ataglance.html
Not all People with
HIV know their status
1,059,784 PWH 2019
http://www.cdc.gov/hiv/statistics/overview/ataglance.html
Undiagnosed HIV (2019)
8
CDC. Estimated HIV incidence and prevalence in the United States 2015-2019.
HIV Surveillance Supplemental Report 2021
In U.S., 13% don’t
know their status
In SCAETC region,
17-20% don’t know
their status
Late-stage diagnosis is associated with more
morbidity and potential increased transmission
Natural history of HIV:
steady decline in CD4 count
Late-stage diagnosis (2017)
9
Centers for Disease Control and Prevention. Monitoring selected national HIV prevention and care objectives by using HIV surveillance data—
United States and 6 U.S. dependent areas, 2017. HIV Surveillance Supplemental Report. 2019;24(No. 3):1-74. Published June 2019
HIV Treatment is Prevention
10
Cohen, et al. NEJM 2011; 365: 493-505. Skarbinski J, et al. JAMA Intern Med 2015;175:588-96.
Bavinton BR, et al. Lancet HIV. 2018. IAS 2018 Conferencehttp://programme.aids2018.org/Abstract/Abstract/13470
HIV Screening Guidelines
CDC 2006
 Test all pregnant women
 Test all pts 13-64 yo
 Test all pts with TB, STI
 Test high risk patients at
least annually
USPTF 2013
• Test all 15-65 yo
• Test <15 & >65 yo if at risk
• Test all pregnant women
• Grade A recommendation
11
Branson BM, et al. MMWR 2006. Moyer, Virginia et al. Annals of Internal Medicine. 2013.
Status Neutral HIV Screening & Linkage to Care
 Making HIV screening part of routine care helps ensure
patients are screened, despite presumed risk, and helps
reduce stigma
 If HIV screen nonreactive/negative but significant risk,
linkage to HIV prevention (i.e. PEP, PrEP)
 If HIV screen reactive/positive, linkage to HIV treatment
(antiretroviral therapy and holistic care)
12
HIV Transmission Risk
Not infectious:
 Urine, saliva,
sweat, tears,
nasal secretions,
sputum, vomitus,
stool
13
https://www.cdc.gov/hiv/risk/estimates/riskbehaviors.html
Image: https://healthylife.werindia.com/your-road-to-healthy-life/hiv-is-not-transmitted-by
HIV Transmission Risk
 Potentially infectious
fluids: blood, breast
milk, tissue, semen,
vaginal secretions,
visibly bloody fluids
 Exposure across
mucosal surface, open
wound, or injection
14
https://www.cdc.gov/hiv/risk/estimates/riskbehaviors.html
HIV Treatment in Birthing Parent
Prevents Vertical Transmission
15
• Without antiretroviral therapy (ART)
• 40% if breastfeeding off ART
25%
• Birthing parent takes perinatal ART
• Labor ART +/- IV zidovudine (AZT)
• Neonate oral zidovudine (AZT)
<1%
PEP vs PrEP
 HIV PEP = post-
exposure prophylaxis​
 Given after high-
risk exposure to reduce
risk of HIV infection​
 Start within 72 hours
of exposure​
 28-day course of oral
daily 3-drug regimen​
 HIV PrEP = pre-
exposure prophylaxis​
 Daily regimen
given before exposure to
reduce risk of HIV
infection​
 Oral 2-drug regimen or
long-acting injectable
medication
16
https://www.cdc.gov/hiv/pdf/programresources/cdc-hiv-npep-guidelines.pdf ​
https://www.cdc.gov/hiv/pdf/risk/prep/cdc-hiv-prep-guidelines-2021.pdf
PrEP Coverage
17
CDC. Monitoring selected national HIV prevention and care objectives by using HIV surveillance
data—United States and 6 dependent areas, 2019. HIV Surveillance Supplemental Report 2021
Nationally,
23% of the
people who are
considered at
considerable risk
of HIV infections
are receiving pre-
exposure
prophylaxis
18
CDC. Monitoring selected national HIV prevention and care objectives by using HIV surveillance
data—United States and 6 dependent areas, 2019. HIV Surveillance Supplemental Report 2021
PrEP Access is Improving
 20 Urban areas in US
from 2014-2017
 PrEP awareness among
MSM increased
 PrEP use increased
Awareness Use
0
10
20
30
40
50
60
70
80
90
100
PrEP among MSM
2014 2017
Finlayson, E et al. MMWR July 12,2019. 68(27).
Need for PrEP to reach more people at risk
 Continued disparities among
certain populations with
new HIV infections
and lack of access to HIV PrEP
 Interventions to improve
metrics at each step
of
PrEP care Continuum
could reduce
disparities
Jenness, S et al. CROI2018. Abstract 1149
PrEP Uptake
Barriers
 Poor access to health care in
the most at-risk communities
 Competing priorities – housing,
transportation, employment
 Limited risk awareness and HIV
prevention education among
many vulnerable populations
 Provider preconceived notions
Solutions
 Care navigation and Medicaid
expansion
 Address social determinants of
health
 Public education about risk and
harm reduction
 Provider education and cultural
literacy
21
Resources
 National Clinician Consultation
Center http://nccc.ucsf.edu/
 HIV Management
 Perinatal HIV
 HIV PrEP
 HIV PEP line
 HCV Management
 Substance Use Management
 Present case on ECHO
https://echo.unm.edu/locations-2/ec
ho-hubs-superhubs-united-states/
 AETC National HIV
Curriculum
https://aidsetc.org/nhc
 AETC National Coordinating
Resource Center
https://targethiv.org/library/aet
c-national-coordinating-resou
rce-center-0
 Additional trainings
scaetcecho@salud.unm.edu
 www.scaetc.org
22

More Related Content

PDF
Global Medical Cures™ | HIV TESTING IN USA
PPTX
HJS_HIVSurveyProject
PPTX
National aids control programme
DOCX
HIVinterventionstrategy
PPTX
HATS_Medwiser_A
PPTX
Integrating HIV Prevention into Primary Care
PPT
A new options for hiv prevention slides.2013
PDF
HIVScreeningApproved
Global Medical Cures™ | HIV TESTING IN USA
HJS_HIVSurveyProject
National aids control programme
HIVinterventionstrategy
HATS_Medwiser_A
Integrating HIV Prevention into Primary Care
A new options for hiv prevention slides.2013
HIVScreeningApproved

Similar to SCAETC BPHC_HIV Epi and Screening_Iandiorio.pptx (20)

PPTX
2014 Epidemiological Update by Dr. Kathleen Brady
PPT
NASTAD National HIV Prevention Inventory
PPTX
Webinar on Integrating HIV Education
PPTX
Where are we on HIV testing services - the achievements and the gaps
PDF
Sustaining the HIV and AIDS Response in St. Vincent and the Grenadines: Inves...
PPTX
11.13.20 | The Impact of COVID-19 on the Opioid Epidemic
PPTX
Hiv &amp;ictc seminar by Dr. Mousumi Sarkar
PDF
pozabilities_newsletter_vol3_web
PDF
Determinants of HIV Status Disclosure among Adolescents in Bondo Sub-county o...
DOCX
e632 www.thelancet.comhiv Vol 6 September 2019Viewpoi
PDF
Statement of intent
PPT
A New Options for HIV Prevention.The Role of Antiretrovirals
PPTX
View only rx16 prev tues_1230_1_duwve_2adams_3proescholdbell-sachdeva
PPT
HIV Epidemiology in the Prairies
PDF
A Community Assessment of Nutritional Needs/Status of HIV/AIDS among Latinos ...
PDF
international-archives-of-nursing-and-health-care-ianhc-10-195.pdf
DOCX
Read the article on the following 2 pages, Fighting HIV a Commu.docx
PPT
HIVProjectProgressPoster[1]
PPTX
HIV Prevention in the Biomedical Era, presented by Brett Palmer
2014 Epidemiological Update by Dr. Kathleen Brady
NASTAD National HIV Prevention Inventory
Webinar on Integrating HIV Education
Where are we on HIV testing services - the achievements and the gaps
Sustaining the HIV and AIDS Response in St. Vincent and the Grenadines: Inves...
11.13.20 | The Impact of COVID-19 on the Opioid Epidemic
Hiv &amp;ictc seminar by Dr. Mousumi Sarkar
pozabilities_newsletter_vol3_web
Determinants of HIV Status Disclosure among Adolescents in Bondo Sub-county o...
e632 www.thelancet.comhiv Vol 6 September 2019Viewpoi
Statement of intent
A New Options for HIV Prevention.The Role of Antiretrovirals
View only rx16 prev tues_1230_1_duwve_2adams_3proescholdbell-sachdeva
HIV Epidemiology in the Prairies
A Community Assessment of Nutritional Needs/Status of HIV/AIDS among Latinos ...
international-archives-of-nursing-and-health-care-ianhc-10-195.pdf
Read the article on the following 2 pages, Fighting HIV a Commu.docx
HIVProjectProgressPoster[1]
HIV Prevention in the Biomedical Era, presented by Brett Palmer
Ad

Recently uploaded (20)

PPTX
FORENSIC MEDICINE and branches of forensic medicine.pptx
PDF
Diabetes mellitus - AMBOSS.pdf
PPTX
Approach to Abdominal trauma Gemme(COMMENT).pptx
PDF
Tackling Intensified Climatic Civil and Meteorological Aviation Weather Chall...
PDF
Nematodes - by Sanjan PV 20-52.pdf based on all aspects
PPTX
IMMUNITY ... and basic concept mds 1st year
PPTX
Local Anesthesia Local Anesthesia Local Anesthesia
PPSX
Man & Medicine power point presentation for the first year MBBS students
PPTX
GAIT IN HUMAN AMD PATHOLOGICAL GAIT ...............
PPTX
A Detailed Physiology of Endocrine System.pptx
PDF
Seizures and epilepsy (neurological disorder)- AMBOSS.pdf
PDF
Integrating Traditional Medicine with Modern Engineering Solutions (www.kiu....
PPTX
LIVER DIORDERS OF PREGNANCY in detail PPT.pptx
PPTX
Approch to weakness &paralysis pateint.pptx
PPTX
Phamacology Presentation (Anti cance drugs).pptx
PPTX
ANTI BIOTICS. SULPHONAMIDES,QUINOLONES.pptx
PPTX
Genetics and health: study of genes and their roles in inheritance
PPTX
Surgical anatomy, physiology and procedures of esophagus.pptx
PDF
neonatology-for-nurses.pdfggghjjkkkkkkjhhg
PDF
Gonadotropin-releasing hormone agonist versus HCG for oocyte triggering in an...
FORENSIC MEDICINE and branches of forensic medicine.pptx
Diabetes mellitus - AMBOSS.pdf
Approach to Abdominal trauma Gemme(COMMENT).pptx
Tackling Intensified Climatic Civil and Meteorological Aviation Weather Chall...
Nematodes - by Sanjan PV 20-52.pdf based on all aspects
IMMUNITY ... and basic concept mds 1st year
Local Anesthesia Local Anesthesia Local Anesthesia
Man & Medicine power point presentation for the first year MBBS students
GAIT IN HUMAN AMD PATHOLOGICAL GAIT ...............
A Detailed Physiology of Endocrine System.pptx
Seizures and epilepsy (neurological disorder)- AMBOSS.pdf
Integrating Traditional Medicine with Modern Engineering Solutions (www.kiu....
LIVER DIORDERS OF PREGNANCY in detail PPT.pptx
Approch to weakness &paralysis pateint.pptx
Phamacology Presentation (Anti cance drugs).pptx
ANTI BIOTICS. SULPHONAMIDES,QUINOLONES.pptx
Genetics and health: study of genes and their roles in inheritance
Surgical anatomy, physiology and procedures of esophagus.pptx
neonatology-for-nurses.pdfggghjjkkkkkkjhhg
Gonadotropin-releasing hormone agonist versus HCG for oocyte triggering in an...
Ad

SCAETC BPHC_HIV Epi and Screening_Iandiorio.pptx

  • 1. Ending the HIV Epidemic: HIV Testing & Prevention TeleECHO Series 1 HIV Epidemiology & Screening Guidelines
  • 3. Disclosures  Original slide developer: Michelle Iandiorio, MD  Clinical Director, SCAETC; Professor, UNMHSC Dept of Internal Med, Division of Infectious Diseases  Slide developer has no financial conflicts of interest to disclose  Slide presenter has spoken for Merck in the past 3 This program is supported by the Health Resources and Services Administration (HRSA) of the U.S. Department of Health and Human Services (HHS) as part of an award totaling $3,132,205, with 0% financed with non-governmental sources. The views expressed do not necessarily reflect the official policies of the Department of Health and Human Services, nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government. Any trade/brand names for products mentioned during this presentation are for training and identification purposes only. This project is supported by funds from the Bureau of Primary Care.
  • 4. Learning Objectives 1. Recognize the need for HIV screening and prevention. 2. Recognize disparities in accessing HIV prevention. 3. Identify HIV screening guidelines and explain why HIV screening is routine best practice. 4. Explain status neutral linkage to care. 4
  • 5. There have been improvements in reduction of new HIV diagnoses…  Annual number of new diagnoses decreased 8% from 2015 to 2019 in U.S. (36,000)  Majority of new diagnoses in men with male sex partners  From 2010 to 2019, HIV diagnoses decreased among youth overall  2019 HIV infections decreased among 13- 24yo by 46% https://www.cdc.gov/hiv/statistics/overview/ataglance.html
  • 6. … But Disparities Still Exist  New HIV diagnoses in Native American population increased 22% between 2015 to 2019 (31% in Native American men with male sex partners)  From 2010 to 2016, HIV diagnoses increased 6% among Latinx  The most affected subpopulation is African American/Black gay and bisexual men https://www.cdc.gov/hiv/statistics/overview/ataglance.html MSM=men who have sex with men https://www.cdc.gov/hiv/statistics/overview/ataglance.html
  • 7. Not all People with HIV know their status 1,059,784 PWH 2019 http://www.cdc.gov/hiv/statistics/overview/ataglance.html
  • 8. Undiagnosed HIV (2019) 8 CDC. Estimated HIV incidence and prevalence in the United States 2015-2019. HIV Surveillance Supplemental Report 2021 In U.S., 13% don’t know their status In SCAETC region, 17-20% don’t know their status
  • 9. Late-stage diagnosis is associated with more morbidity and potential increased transmission Natural history of HIV: steady decline in CD4 count Late-stage diagnosis (2017) 9 Centers for Disease Control and Prevention. Monitoring selected national HIV prevention and care objectives by using HIV surveillance data— United States and 6 U.S. dependent areas, 2017. HIV Surveillance Supplemental Report. 2019;24(No. 3):1-74. Published June 2019
  • 10. HIV Treatment is Prevention 10 Cohen, et al. NEJM 2011; 365: 493-505. Skarbinski J, et al. JAMA Intern Med 2015;175:588-96. Bavinton BR, et al. Lancet HIV. 2018. IAS 2018 Conferencehttp://programme.aids2018.org/Abstract/Abstract/13470
  • 11. HIV Screening Guidelines CDC 2006  Test all pregnant women  Test all pts 13-64 yo  Test all pts with TB, STI  Test high risk patients at least annually USPTF 2013 • Test all 15-65 yo • Test <15 & >65 yo if at risk • Test all pregnant women • Grade A recommendation 11 Branson BM, et al. MMWR 2006. Moyer, Virginia et al. Annals of Internal Medicine. 2013.
  • 12. Status Neutral HIV Screening & Linkage to Care  Making HIV screening part of routine care helps ensure patients are screened, despite presumed risk, and helps reduce stigma  If HIV screen nonreactive/negative but significant risk, linkage to HIV prevention (i.e. PEP, PrEP)  If HIV screen reactive/positive, linkage to HIV treatment (antiretroviral therapy and holistic care) 12
  • 13. HIV Transmission Risk Not infectious:  Urine, saliva, sweat, tears, nasal secretions, sputum, vomitus, stool 13 https://www.cdc.gov/hiv/risk/estimates/riskbehaviors.html Image: https://healthylife.werindia.com/your-road-to-healthy-life/hiv-is-not-transmitted-by
  • 14. HIV Transmission Risk  Potentially infectious fluids: blood, breast milk, tissue, semen, vaginal secretions, visibly bloody fluids  Exposure across mucosal surface, open wound, or injection 14 https://www.cdc.gov/hiv/risk/estimates/riskbehaviors.html
  • 15. HIV Treatment in Birthing Parent Prevents Vertical Transmission 15 • Without antiretroviral therapy (ART) • 40% if breastfeeding off ART 25% • Birthing parent takes perinatal ART • Labor ART +/- IV zidovudine (AZT) • Neonate oral zidovudine (AZT) <1%
  • 16. PEP vs PrEP  HIV PEP = post- exposure prophylaxis​  Given after high- risk exposure to reduce risk of HIV infection​  Start within 72 hours of exposure​  28-day course of oral daily 3-drug regimen​  HIV PrEP = pre- exposure prophylaxis​  Daily regimen given before exposure to reduce risk of HIV infection​  Oral 2-drug regimen or long-acting injectable medication 16 https://www.cdc.gov/hiv/pdf/programresources/cdc-hiv-npep-guidelines.pdf ​ https://www.cdc.gov/hiv/pdf/risk/prep/cdc-hiv-prep-guidelines-2021.pdf
  • 17. PrEP Coverage 17 CDC. Monitoring selected national HIV prevention and care objectives by using HIV surveillance data—United States and 6 dependent areas, 2019. HIV Surveillance Supplemental Report 2021 Nationally, 23% of the people who are considered at considerable risk of HIV infections are receiving pre- exposure prophylaxis
  • 18. 18 CDC. Monitoring selected national HIV prevention and care objectives by using HIV surveillance data—United States and 6 dependent areas, 2019. HIV Surveillance Supplemental Report 2021
  • 19. PrEP Access is Improving  20 Urban areas in US from 2014-2017  PrEP awareness among MSM increased  PrEP use increased Awareness Use 0 10 20 30 40 50 60 70 80 90 100 PrEP among MSM 2014 2017 Finlayson, E et al. MMWR July 12,2019. 68(27).
  • 20. Need for PrEP to reach more people at risk  Continued disparities among certain populations with new HIV infections and lack of access to HIV PrEP  Interventions to improve metrics at each step of PrEP care Continuum could reduce disparities Jenness, S et al. CROI2018. Abstract 1149
  • 21. PrEP Uptake Barriers  Poor access to health care in the most at-risk communities  Competing priorities – housing, transportation, employment  Limited risk awareness and HIV prevention education among many vulnerable populations  Provider preconceived notions Solutions  Care navigation and Medicaid expansion  Address social determinants of health  Public education about risk and harm reduction  Provider education and cultural literacy 21
  • 22. Resources  National Clinician Consultation Center http://nccc.ucsf.edu/  HIV Management  Perinatal HIV  HIV PrEP  HIV PEP line  HCV Management  Substance Use Management  Present case on ECHO https://echo.unm.edu/locations-2/ec ho-hubs-superhubs-united-states/  AETC National HIV Curriculum https://aidsetc.org/nhc  AETC National Coordinating Resource Center https://targethiv.org/library/aet c-national-coordinating-resou rce-center-0  Additional trainings [email protected]  www.scaetc.org 22

Editor's Notes

  • #1: Version date_12 2021 Target audience: Medical providers (physicians, nurse practitioners, physician assistants, pharmacists, nurses, medical assistants) Behavioral health providers Case managers Outreach workers Dental professionals (dentists, hygienists, dental assistants) Healthcare student learners Clinic administrators
  • #3: Presenters – please add your relevant financial disclosures to this slide.
  • #4: Recognize the need for HIV screening and prevention (epidemiology, transmission risk, risk of progression of immunosuppression and immune dysregulation). Recognize disparities in accessing HIV prevention and treatment (epidemiology and access to services). Identify HIV screening guidelines (transmission risk without stigmatization) and explain why HIV screening is routine best practice. Explain status neutral linkage to care.
  • #5: Trend in new infections from 2010 to 2019 40,000 ISH to 36,000 ISH. Slide Sets | Resource Library | HIV/AIDS | CDC: www.cdc.gov Goal with EHE is 2025 – approximately 8000 to 9000 new infections; 2030 - <3000 new infections 2018 HIV Surveillance Report The annual number of new diagnoses decreased 9% from 2010 to 2016 in the 50 states and the District of Columbia. In 2018, gay, bisexual, and other men who have sex with men accounted for 69% of all new HIV diagnoses in the United States and 6 dependent areas. In the same year, heterosexuals made up 24% of all HIV diagnoses From 2010 to 2017, HIV diagnoses decreased 10% among youth overall in the 50 states and the District of Columbia. In 2018, youth aged 13 to 24a made up 21% (men: 92% MSM; women: 85% WSM, 12% IDU) 2019 surveillance report The annual number of HIV infections in 2019, compared with 2010, increased among persons aged 25–34 years (35%), but decreased among persons aged 13–24 (−46%) and 45–54 years (−36%).  The annual number of HIV infections in 2019, compared with 2010, decreased among persons with infection attributed to heterosexual contact (−24%). The annual numbers remained stable among persons with infection attributed to injection drug use (IDU), male-to-male sexual contact (MMSC), and MMSC and IDU.
  • #6: 2018 HIV Surveillance Report The most affected subpopulation is African American gay and bisexual men (42% of new HIV diagnoses in 2018 with accounted for 13% of the US population) Rates of Diagnoses of HIV Infection among Adults and Adolescents, by Age at Diagnosis, 2008–2012—U.S. 50,000 new patients infected with HIV/yr. http://www.cdc.gov/hiv/library/reports/surveillance/ 37,600 new patients infected with HIV/yr in the U.S.2014 Highest increases in youth (13-25), MSM, racial minorities Implies the need for alternatives/additions to condoms Additional statistics about disparities 2 out of every 5 patients newly diagnosed with HIV are youth African American MSM have 5x the national average of new HIV diagnoses. African Americans make up 12% of US population but 44% of new HIV diagnoses. One of every 2 women newly infected with HIV is African American. New HIV diagnoses in Native American population increased 19% between 2005 to 2014 & 63% in MSM Transgender patients have 3x the national average of new HIV diagnoses Hispanics make up 18% of US population but 25% of new HIV diagnoses. 2019 Surveillance report In 2019, the largest percentage of HIV infections were attributed to MMSC (66%), followed by heterosexual contact (22%). In 2019, Black/African American persons made up approximately 12% of the population of the United States but accounted for 41% of HIV infections. White persons made up 62% of the population of the United States but accounted for 25% of HIV infections. Hispanic/Latino persons made up 17% of the population of the United States but accounted for 29% of HIV infections. The estimated HIV incidence for American Indian/Alaskan Native persons should be used with caution because the RSE is 30%–50% .
  • #7: PWH= people with HIV 13% don’t know their status (1 in 7.5 don’t know it) 36,801 new hiv dx in US and dependent areas in 2019. Of those, 69% gay and bisexual men, 23% heterosexual, 7% IDU Number highest among 25-34yo Transgender people: 2% MTF, 1% FTM 86% male Rates of Diagnoses of HIV Infection among Adults and Adolescents, by Age at Diagnosis, 2008–2012—U.S. 50,000 new patients infected with HIV/yr. CDC. MMWR 2015;64:657-662 (2012 data). Estimated 1 in 8 HIV-infected women in the U.S. do not know their status -13% general US population- 44% of 13-24yo do not know http://www.cdc.gov/hiv/library/reports/surveillance/ NM: We have roughly 3,300 persons living with HIV. And average 131 new infections per year. 119 in 2012 – 142 in 2013 – 129 in 2014, 133 in 2015 – 134 in 2016 CDC. MMWR 2015;64:657-662 (2012 data). Estimated 1 in 8 HIV-infected women in the U.S. do not know their status -13% general US population- 44% of 13-24yo do not know http://www.cdc.gov/hiv/library/reports/surveillance/
  • #8: Estimated 13% of people in the US living with HIV infection are unaware of their diagnosis Darker the color, the fewer the people with HIV have been diagnosed HIV Screening is Important for Prevention & Treatment of HIV. Those who don’t know their status thought to account for 30-50% of new infections (Marks, et al. 2006)
  • #9: 2017 data This means that patients have had undiagnosed HIV infections for about 10 years. Stage 3 HIV: CD4<200 or CD4<14% or any CD4 with active opportunistic infection or malignancy HIV Screening is Important for Treatment of HIV 21% new HIV diagnoses in the U.S. already have advanced disease (21% stage 3, 51% stage 2+3) People who know they are infected can start HIV treatment HIV treatment (HAART/ART) results in viral suppression and markedly reduced transmission1-3 Studies show the benefit of ART on all people with HIV (PWH)4,5 1. Cohen MS, et al. NEJM 2011;365:493-505. 2. Skarbinski J, et al.  JAMA Intern Med 2015;175:588-96. 3. Rodger AJ et al. JAMA 2016;316(2):1-11. 4. Smith et al. JAIDS 2013; 63S2:S187-99. 5. Kitahata MM, et al. NEJM 2009;360:1815-26.
  • #11: STI= sexually transmitted infection Branson BM, et al. MMWR Recomm Rep. 2006;55(RR-14):1-17. Thought that those who don’t know their status account for 50% of new infections (Marks, et al. 2006) Verbal consent for testing (written consent no longer needed) https://www.uspreventiveservicestaskforce.org/uspstf/document/RecommendationStatementFinal/prevention-of-human-immunodeficiency-virus-hiv-infection-pre-exposure-prophylaxis
  • #12: PEP=post-exposure prophylaxs; PrEP=pre-exposure prophylaxis HIV Screening is Important for Prevention Knowing they have HIV allows people to Protect others from becoming infected Make safer decisions about sex, needle use, & their health care PWH who know their status avoid behaviors that spread infection Those at high risk but test negative can utilize prevention strategies Coates, et al JAMA 1987;258:1889. Doll et al. Health Psychol 1990;9:253-65. Fox, et al. AIDS 1987;1:241-6. Gibson, et al. AIDS and Behavior 1999;3:3-12. Rietmeijer, et al. AIDS 1996; 10:291-8. van Griensven et al. Am J Epidemiol
  • #13: Status neutral approach. Screen all patients for HIV and all those with history sexual activity for STIs. Inform all patients about HIV transmission risk – for their own use, to help spread reliable information to communities, to reduce spread of misinformation, to reduce stigma
  • #14: Risk reduction approach Empower patients to make risk assessment and behavior decisions for themselves based on scientific information Potentially infectious fluids also include visibly bloody fluids, other bodily fluids (cerebral spinal fluid, synovial fluid, pleural fluid, pericardial fluid, amniotic fluid) Higher risk: Receptive anal sex (Per episode: 0.3 - 3%), Needle sharing (Per episode: 0.67%) Lower risk: Oral sex (Per episode: 0.06%) Insertive sex (Per episode 0.03 – 0.14%) 1. Bell DM. Am J Med 1997;102(suppl5B):9--15. 2. Ippolito G et al. Arch Int Med 1993;153:1451--8. 3. Am J Epi 1999; 150:306-11.4. Am J Epi 1999;150:306-11.5. MMWR 47;RR-17, 1998.6. NEJM 336(15):1072-8. 7. Am J Epi 1999;150:306-11.8. Rothenberg RB et al. AIDS 1998;12:2095-2105.9. MMWR 47;RR-17, 1998.10. ACTG 076
  • #15: Higher rate in Asia and Africa (25-40%): other medical conditions, prolonged breastfeeding 1999 study of 57 woman who had viral loads <1000 at delivery, none had hiv infected babies (irrespective if on haart or not) Plasma viremia is significant risk: rate of vertical transmission 3.4 gold higher per log of plasma viremia. Give AZT even if resistance: crosses placenta readily, reduces genital viral load
  • #17: CDC. Monitoring selected national HIV prevention and care objectives by using HIV surveillance data—United States and 6 dependent areas, 2019. HIV Surveillance Supplemental Report 2021 Nationally, rates of PrEP use are around 23%, which is to say that 23% of the people who are considered at considerable risk of HIV infections are receiving pre-exposure prophylaxis
  • #18: People of color comprise a disproportionate number of new HIV infections in the US, yet have limited uptake of PrEP PrEP has been most widely adopted by college educated, middle-aged, white gay men Many LGBTQ+ community centers across the US are based in neighborhoods most popular for white gay men If we look at it from a gender perspective, Men have at least 3x higher PrEP coverage than woman Black heterosexual woman have higher rates of HIV acquisition than other women CDC, 2016 Though 20% of the US population, Latinx people account for ¼ of new cases of HIV. Most of those diagnosed are men Awareness of PrEP is low among Latinx individuals at risk, particularly MSM, posing challenges to adoption Stigma or fear of being judged for one’s behaviors may serve as a barrier to PrEP adoption, as well as linguistic and economic access to resources in some regions
  • #19: Finlayson, T et al. Changes In HIV PrEP Awareness and Use among MSM – 20 urban areas, 2014 and 2017. MMWR, 7/12/19. PrEP awareness among MSM increased from 60% to 90% PrEP use increased from 6% to 35%
  • #20: -Jenness, S et al. CROI2018. The PrEP care continuum and HIV racial disparities among MSM. Abstract 1149. Mathematical model of HIV transmission for MSM to include race-stratefied transitions through PrEP continuing from awareness to access to rx to adherence to retention. https://www.cdc.gov/mmwr/volumes/68/wr/pdfs/mm6827-H.pdf
  • #22: Find an HIV-related topic TeleECHO in your area: https://echo.unm.edu/locations-2/echo-hubs-superhubs-united-states/ IDEA Platform: Infectious Diseases Education & Assessment. https://idea.medicine.uw.edu/ AETC National HIV Curriculum: 6 core modules for self study; regularly updated; CME, CNE Hepatitis C Online Curriculum: https://www.hepatitisc.uw.edu/ Hepatitis B Online Curriculum: https://www.hepatitisb.uw.edu/ National STD Curriculum: https://www.std.uw.edu/